Effects of Sex on Mortality in Patients With Lung Cancer: A Multiple Mediation Analysis of The Boston Lung Cancer Study
Clinical Lung Cancer · 2026-03 · 27 (2) · 201-209.e3
DOI: 10.1016/j.cllc.2025.09.007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Lung Cancer, 2026-03. Verfasst von Adriana Araceli Rodriguez Alvarez und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Massachusetts General Hospital, Boston, MA. Electronic address: arodriguez@mgh.harvard.edu. Hauptthemen laut MEDLINE: Lung Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, Ralph W and Grace M Showalter Research Trust Fund, National Cancer Institute.
Abstract (Originalsprache)
OBJECTIVE: Identify the specific variables that can explain the sex difference in lung cancer mortality. MATERIAL AND METHODS: This retrospective cohort study analyzed data from the Boston Lung Cancer Study (1992-2022). We employed descriptive statistics, Wilcoxon rank-sum test, and Pearson's Chi-square test to compare demographic and clinical variables by sex. Kaplan-Meier survival curves and Cox proportional hazards models were used to evaluate survival differences. Mediation analysis was conducted to investigate causal pathways through which sex influences mortality, incorporating cancer stage, smoking status, and treatment modalities. RESULTS: Among 7642 patients, 53.7% were women. Men were older, had heavier smoking histories, and more frequently received chemotherapy and radiotherapy, whereas women underwent more surgeries. Median survival was significantly longer for women (4.54 vs. 2.59 years), with a 29% reduced hazard of lung cancer-related death (HR: 0.71; 95% CI, 0.66-0.75; P < .0001). Approximately 32% of this survival difference was mediated by early-stage diagnosis, surgical intervention, and smoking history. CONCLUSION: Women exhibited a survival advantage, of which only about one-third was explained by earlier diagnosis and higher surgical intervention rates. The remaining two-thirds of the mortality difference remains unexplained. Addressing these modifiable factors may reduce sex inequalities in lung cancer outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, Massachusetts General Hospital, Boston, MA. Electronic address: arodriguez@mgh.harvard.edu.
- Department of Mathematics, College of William & Mary, Williamsburg, VA.
- Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor, MI.
- Department of Medicine, Massachusetts General Hospital, Boston, MA; Departments of Environmental Health and Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA.
Förderung
- NCI NIH HHS
- Ralph W and Grace M Showalter Research Trust Fund
- National Cancer Institute
- National Institutes of Health
- Foundation for the National Institutes of Health
Zitieren
APA
Alvarez, A. A. R., Sun, Y., Li, Y., & Christiani, D. C. (2026). Effects of Sex on Mortality in Patients With Lung Cancer: A Multiple Mediation Analysis of The Boston Lung Cancer Study. Clinical Lung Cancer, 27(2), 201-209.e3. https://doi.org/10.1016/j.cllc.2025.09.007
Vancouver
Alvarez AAR, Sun Y, Li Y, Christiani DC. Effects of Sex on Mortality in Patients With Lung Cancer: A Multiple Mediation Analysis of The Boston Lung Cancer Study. Clinical Lung Cancer. 2026;27(2):201-209.e3. doi:10.1016/j.cllc.2025.09.007
BibTeX
@article{Alvarez2026,
author = {Alvarez, Adriana Araceli Rodriguez and Sun, Yuming and Li, Yi and Christiani, David C},
title = {Effects of Sex on Mortality in Patients With Lung Cancer: A Multiple Mediation Analysis of The Boston Lung Cancer Study},
journal = {Clinical Lung Cancer},
year = {2026},
volume = {27},
number = {2},
pages = {201--209.e3},
doi = {10.1016/j.cllc.2025.09.007}
}
EUVIMED